Pandey Rishabh, 2Singh AV, Pandey Awanish, Tripathi Poonam, SK Majumdar, Nath LK
1*Pandey Rishabh, 2Singh AV, 1Pandey Awanish, 1Tripathi Poonam, 1SK Majumdar and 2Nath LK
1Institute of technology and Management, Gorakhpur (UP) India
2Department of Pharmaceutical Sciences, Dibrugarh University, Assam, India
Volume - 2,
Issue - 2,
Year - 2009
Peptides and proteins continue to grow in popularity for their potential use in current drug therapy and protein drug market will reach $ 55.7 billion by the end of 2011. Protein and Peptide products for therapeutic use include a very diverse range of product as Hormones, Growth factors, cytokines, vaccines and Monoclonal antibodies. Biotechnology has given many ways for the production of protein based drugs as Hybridoma cell technology, Recombinant DNA technology and transgenic animals. Different Technologies are developed for the improved delivery of protein therapeutics but there are number of safety issues, relating to protein products that differ from those raised by low molecular weight products.
Cite this article:
Pandey Rishabh, 2Singh AV, Pandey Awanish, Tripathi Poonam, SK Majumdar, Nath LK. Protein and Peptide Drugs: A Brief Review. Research J. Pharm. and Tech. 2(2): April.-June.2009,;Page 228-233.